372 related articles for article (PubMed ID: 31667620)
1. The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.
McAlister L; Pugh P; Greenbaum L; Haffner D; Rees L; Anderson C; Desloovere A; Nelms C; Oosterveld M; Paglialonga F; Polderman N; Qizalbash L; Renken-Terhaerdt J; Tuokkola J; Warady B; Walle JV; Shaw V; Shroff R
Pediatr Nephrol; 2020 Mar; 35(3):501-518. PubMed ID: 31667620
[TBL] [Abstract][Full Text] [Related]
2. Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.
Shaw V; Polderman N; Renken-Terhaerdt J; Paglialonga F; Oosterveld M; Tuokkola J; Anderson C; Desloovere A; Greenbaum L; Haffner D; Nelms C; Qizalbash L; Vande Walle J; Warady B; Shroff R; Rees L
Pediatr Nephrol; 2020 Mar; 35(3):519-531. PubMed ID: 31845057
[TBL] [Abstract][Full Text] [Related]
3. The dietary management of potassium in children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.
Desloovere A; Renken-Terhaerdt J; Tuokkola J; Shaw V; Greenbaum LA; Haffner D; Anderson C; Nelms CL; Oosterveld MJS; Paglialonga F; Polderman N; Qizalbash L; Warady BA; Shroff R; Vande Walle J
Pediatr Nephrol; 2021 Jun; 36(6):1331-1346. PubMed ID: 33730284
[TBL] [Abstract][Full Text] [Related]
4. Assessment and management of obesity and metabolic syndrome in children with CKD stages 2-5 on dialysis and after kidney transplantation-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.
Stabouli S; Polderman N; Nelms CL; Paglialonga F; Oosterveld MJS; Greenbaum LA; Warady BA; Anderson C; Haffner D; Desloovere A; Qizalbash L; Renken-Terhaerdt J; Tuokkola J; Walle JV; Shaw V; Mitsnefes M; Shroff R
Pediatr Nephrol; 2022 Jan; 37(1):1-20. PubMed ID: 34374836
[TBL] [Abstract][Full Text] [Related]
5. Assessment of nutritional status in children with kidney diseases-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.
Nelms CL; Shaw V; Greenbaum LA; Anderson C; Desloovere A; Haffner D; Oosterveld MJS; Paglialonga F; Polderman N; Qizalbash L; Rees L; Renken-Terhaerdt J; Tuokkola J; Vande Walle J; Shroff R; Warady BA
Pediatr Nephrol; 2021 Apr; 36(4):995-1010. PubMed ID: 33319327
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.
Bacchetta J; Schmitt CP; Bakkaloglu SA; Cleghorn S; Leifheit-Nestler M; Prytula A; Ranchin B; Schön A; Stabouli S; Van de Walle J; Vidal E; Haffner D; Shroff R
Pediatr Nephrol; 2023 Sep; 38(9):3163-3181. PubMed ID: 36786859
[TBL] [Abstract][Full Text] [Related]
7. Dietary calcium intake does not meet the nutritional requirements of children with chronic kidney disease and on dialysis.
McAlister L; Silva S; Shaw V; Shroff R
Pediatr Nephrol; 2020 Oct; 35(10):1915-1923. PubMed ID: 32385527
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hyperphosphatemia: the dangers of aiming for normal PTH levels.
Haffner D; Leifheit-Nestler M
Pediatr Nephrol; 2020 Mar; 35(3):485-491. PubMed ID: 31823044
[TBL] [Abstract][Full Text] [Related]
9. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hyperphosphatemia: the dangers of high PTH levels.
Bacchetta J
Pediatr Nephrol; 2020 Mar; 35(3):493-500. PubMed ID: 31696357
[TBL] [Abstract][Full Text] [Related]
11. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure.
Cernaro V; Longhitano E; Calabrese V; Casuscelli C; Di Carlo S; Spinella C; Gembillo G; Santoro D
Expert Opin Pharmacother; 2023; 24(15):1737-1746. PubMed ID: 37527180
[TBL] [Abstract][Full Text] [Related]
12. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
13. Assessment and management of vitamin status in children with CKD stages 2-5, on dialysis and post-transplantation: clinical practice points from the Pediatric Renal Nutrition Taskforce.
Anderson CE; Tuokkola J; Qizalbash L; Harmer M; Nelms CL; Stabouli S; Toole B; Polderman N; Desloovere A; Renken-Terhaerdt J; Vega MRW; Snauwaert E; Walle JV; Haffner D; Paglialonga F; Shroff R; Shaw V; Greenbaum LA; Warady BA
Pediatr Nephrol; 2024 Apr; ():. PubMed ID: 38570350
[TBL] [Abstract][Full Text] [Related]
14. Delivery of a nutritional prescription by enteral tube feeding in children with chronic kidney disease stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.
Rees L; Shaw V; Qizalbash L; Anderson C; Desloovere A; Greenbaum L; Haffner D; Nelms C; Oosterveld M; Paglialonga F; Polderman N; Renken-Terhaerdt J; Tuokkola J; Warady B; Walle JV; Shroff R;
Pediatr Nephrol; 2021 Jan; 36(1):187-204. PubMed ID: 32728841
[TBL] [Abstract][Full Text] [Related]
15. Nutritional management of children with acute kidney injury-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.
Vega MRW; Cerminara D; Desloovere A; Paglialonga F; Renken-Terhaerdt J; Walle JV; Shaw V; Stabouli S; Anderson CE; Haffner D; Nelms CL; Polderman N; Qizalbash L; Tuokkola J; Warady BA; Shroff R; Greenbaum LA
Pediatr Nephrol; 2023 Nov; 38(11):3559-3580. PubMed ID: 36939914
[TBL] [Abstract][Full Text] [Related]
16. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Souqiyyeh MZ; Shaheen FA
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
[TBL] [Abstract][Full Text] [Related]
17. Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement.
Evenepoel P; Jørgensen HS; Bover J; Davenport A; Bacchetta J; Haarhaus M; Hansen D; Gracia-Iguacel C; Ketteler M; McAlister L; White E; Mazzaferro S; Vervloet M; Shroff R
Nephrol Dial Transplant; 2024 Jan; 39(2):341-366. PubMed ID: 37697718
[TBL] [Abstract][Full Text] [Related]
18. The management of dietary fiber intake in children with chronic kidney disease - clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.
Desloovere A; Polderman N; Renken-Terhaerdt J; Shaw V; Anderson C; Greenbaum LA; Nelms CL; Qizalbash L; Stabouli S; Tuokkola J; Warady BA; Vande Walle J; Paglialonga F; Shroff R; Snauwaert E
J Ren Nutr; 2024 Jun; ():. PubMed ID: 38866350
[TBL] [Abstract][Full Text] [Related]
19. Hyperphosphatemia and Chronic Kidney Disease: A Major Daily Concern Both in Adults and in Children.
Bacchetta J; Bernardor J; Garnier C; Naud C; Ranchin B
Calcif Tissue Int; 2021 Jan; 108(1):116-127. PubMed ID: 31996964
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
